Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

A gene deletion in mice causes weak protein, immune issues, hair loss, airway problems, and wasting disease.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Foals can have various skin issues, some genetic, immune-related, or due to infections and allergies.

People with autism are more likely to develop alopecia areata than those without autism.

Copper may protect against alopecia areata, while certain inflammatory markers increase risk.

Oral lichen planus can appear before lichen planopilaris.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

hiPSCs can help regenerate hair follicles and treat hair loss.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Autoimmune reactions may cause both alopecia areata and HAM.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Alopecia areata causes sudden hair loss, often resolves within a year, but can recur.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Alopecia areata may be treated by targeting immune system imbalances.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Stress hormones and autoimmune reactions can cause hair loss.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.